{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:54:36Z","timestamp":1793886876750,"version":"4.8.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["EP\/S021612\/1"],"award-info":[{"award-number":["EP\/S021612\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V033867\/1"],"award-info":[{"award-number":["MR\/V033867\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203328"],"award-info":[{"award-number":["NIHR203328"]}],"id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/22\/10989"],"award-info":[{"award-number":["PG\/22\/10989"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["AA\/18\/6\/34223"],"award-info":[{"award-number":["AA\/18\/6\/34223"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["628.011.213"],"award-info":[{"award-number":["628.011.213"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.atherosclerosis.2024.117462","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T15:30:50Z","timestamp":1706283050000},"page":"117462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Prioritising genetic findings for drug target identification and validation"],"prefix":"10.1016","volume":"390","author":[{"given":"Nikita","family":"Hukerikar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroon D.","family":"Hingorani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert W.","family":"Asselbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Finan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-0424","authenticated-orcid":false,"given":"Amand F.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117462_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117462_bib2","first-page":"2","article-title":"It's all druggable","volume":"49","year":"2017","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117462_bib3","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117462_bib4","doi-asserted-by":"crossref","first-page":"a039230","DOI":"10.1101\/cshperspect.a039230","article-title":"Human genomics and drug development","volume":"12","author":"Schmidt","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117462_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41576-021-00378-0","article-title":"HIV-1 and human genetic variation","volume":"22","author":"McLaren","year":"2021","journal-title":"Nat. Rev. Genet."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117462_bib6","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/CIRCRESAHA.118.311227","article-title":"PCSK9: from basic science discoveries to clinical trials","volume":"122","author":"Shapiro","year":"2018","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117462_bib7","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1111\/bcp.15191","article-title":"Dissecting the IL-6 pathway in cardiometabolic disease: a Mendelian randomization study on both IL6 and IL6R","volume":"88","author":"Cupido","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"9822","key":"10.1016\/j.atherosclerosis.2024.117462_bib8","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117462_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/CS20110340","article-title":"IL-6\/IL-6 receptor system and its role in physiological and pathological conditions","volume":"122","author":"Mihara","year":"2011","journal-title":"Clin. Sci."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117462_bib10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"Supplement_1","key":"10.1016\/j.atherosclerosis.2024.117462_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/ehjacc\/zuad036.131","article-title":"Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development - rationale and design of the DOBERMANN trial","volume":"12","author":"Bo Kunkel","year":"2023","journal-title":"European Heart Journal. Acute Cardiovascular Care"},{"issue":"30","key":"10.1016\/j.atherosclerosis.2024.117462_bib12","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur. Heart J."},{"issue":"15","key":"10.1016\/j.atherosclerosis.2024.117462_bib13","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9965","key":"10.1016\/j.atherosclerosis.2024.117462_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117462_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-25703-3","article-title":"Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease","volume":"12","author":"Schmidt","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117462_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12872-019-1187-z","article-title":"Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9","volume":"19","author":"Schmidt","year":"2019","journal-title":"BMC Cardiovasc. Disord."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117462_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008489","article-title":"Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval","volume":"15","author":"King","year":"2019","journal-title":"PLoS Genet."},{"key":"10.1016\/j.atherosclerosis.2024.117462_bib18","unstructured":"FinnGen: Unique genetic insights from combining isolated population and national health register data | medRxiv\u2019. Accessed: Sep. 01, 2023. [Online]. Available: https:\/\/www.medrxiv.org\/content\/10.1101\/2022.03.03.22271360v1."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117462_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.atherosclerosis.2024.117462_bib20","unstructured":"The Estonian Genome Project - Metspalu - 2004 - Drug Development Research - Wiley Online Library\u2019. Accessed: Sep. 01, 2023. [Online]. Available: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/ddr.10371?casa_token=7u-bQKOCsGwAAAAA:W-DVnk6-oeHJKn5nYrXfRQe4q7fPUtayCzaNZCa9jRShD7q2prNcdnIyHQFEB6oYB9NjW1tlqmRK0H4."},{"issue":"Supplement_III","key":"10.1016\/j.atherosclerosis.2024.117462_bib21","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.je.2016.12.005","article-title":"Overview of the BioBank Japan project: study design and profile","volume":"27","author":"Nagai","year":"2017","journal-title":"J. Epidemiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117462_bib22","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/ije\/dyr120","article-title":"China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up","volume":"40","author":"Chen","year":"2011","journal-title":"Int. J. Epidemiol."},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2024.117462_bib23","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"7789","key":"10.1016\/j.atherosclerosis.2024.117462_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41586-019-1879-7","article-title":"A brief history of human disease genetics","volume":"577","author":"Claussnitzer","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117462_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117462_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nprot.2015.123","article-title":"SIFT missense predictions for genomes","volume":"11","author":"Vaser","year":"2016","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117462_bib27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"issue":"6664","key":"10.1016\/j.atherosclerosis.2024.117462_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"issue":"7809","key":"10.1016\/j.atherosclerosis.2024.117462_bib29","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1038\/s41586-020-2267-z","article-title":"Evaluating drug targets through human loss-of-function genetic variation","volume":"581","author":"Minikel","year":"2020","journal-title":"Nature"},{"issue":"6070","key":"10.1016\/j.atherosclerosis.2024.117462_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1215040","article-title":"A systematic survey of loss-of-function variants in human protein-coding genes","volume":"335","author":"MacArthur","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2024.117462_bib31","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.csbj.2020.06.015","article-title":"Turning genome-wide association study findings into opportunities for drug repositioning","volume":"18","author":"Lau","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117462_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41588-021-00945-5","article-title":"An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci","volume":"53","author":"Mountjoy","year":"2021","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.117462_bib33","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00439-022-02434-z","article-title":"An effector index to predict target genes at GWAS loci","volume":"141","author":"Forgetta","year":"2022","journal-title":"Hum. Genet."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117462_bib34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117462_bib35","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117462_bib36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet. Epidemiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117462_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002872","article-title":"Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes","volume":"13","author":"Georgakis","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.atherosclerosis.2024.117462_bib38","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1038\/s41598-019-45747-2","article-title":"Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: a Mendelian randomization study","volume":"9","author":"Mokry","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117462_bib39","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","article-title":"Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches","volume":"109","author":"Zuber","year":"2022","journal-title":"Am. J. Hum. Genet."},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2024.117462_bib40","doi-asserted-by":"crossref","first-page":"D933","DOI":"10.1093\/nar\/gkac958","article-title":"Ensembl 2023","volume":"51","author":"Martin","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117462_bib41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2024.117462_bib42","doi-asserted-by":"crossref","first-page":"D975","DOI":"10.1093\/nar\/gkt1211","article-title":"NCBI's database of genotypes and phenotypes: dbGaP","volume":"42","author":"Tryka","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"10.1016\/j.atherosclerosis.2024.117462_bib43","doi-asserted-by":"crossref","first-page":"D26","DOI":"10.1093\/nar\/gkl993","article-title":"Entrez Gene: gene-centered information at NCBI","volume":"35","author":"Maglott","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2024.117462_bib44","doi-asserted-by":"crossref","first-page":"D1003","DOI":"10.1093\/nar\/gkac888","article-title":"Genenames.org: the HGNC resources in 2023","volume":"51","author":"Seal","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2024.117462_bib45","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117462_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/0019-5413.139827","article-title":"Medical subject headings (MeSH) terms","volume":"48","author":"Dhammi","year":"2014","journal-title":"Indian J. Orthop."},{"issue":"Database issue","key":"10.1016\/j.atherosclerosis.2024.117462_bib47","doi-asserted-by":"crossref","first-page":"D267","DOI":"10.1093\/nar\/gkh061","article-title":"The unified Medical Language System (UMLS): integrating biomedical terminology","volume":"32","author":"Bodenreider","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"6482","key":"10.1016\/j.atherosclerosis.2024.117462_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"Sj\u00f6stedt","year":"2020","journal-title":"Science"},{"issue":"383","key":"10.1016\/j.atherosclerosis.2024.117462_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development","volume":"9","author":"Finan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117462_bib50","volume":"vol. 64","year":"2012"},{"key":"10.1016\/j.atherosclerosis.2024.117462_bib51","doi-asserted-by":"crossref","unstructured":"Open Targets Platform: supporting systematic drug\u2013target identification and prioritisation | Nucleic Acids Research | Oxford Academic\u2019. Accessed: Sep. 01, 2023. [Online]. Available: https:\/\/academic.oup.com\/nar\/article\/49\/D1\/D1302\/5983621.","DOI":"10.1093\/nar\/gkaa1027"},{"key":"10.1016\/j.atherosclerosis.2024.117462_bib52","unstructured":"PROTAC targeted protein degraders: the past is prologue | Nature Reviews Drug Discovery\u2019. Accessed: Oct. 25, 2023. [Online]. Available: https:\/\/www.nature.com\/articles\/s41573-021-00371-6."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117462_bib53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.atherosclerosis.2024.117462_bib54","unstructured":"The Genotype-Tissue Expression (GTEx) project | Nature Genetics\u2019. Accessed: Aug. 31, 2023. [Online]. Available: https:\/\/www.nature.com\/articles\/ng.2653."},{"issue":"7675","key":"10.1016\/j.atherosclerosis.2024.117462_bib55","first-page":"7675","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"Aguet","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2024.117462_bib56","unstructured":"The Human Protein Atlas\u2019. Accessed: Aug. 25, 2022. [Online]. Available: https:\/\/www.proteinatlas.org\/."},{"key":"10.1016\/j.atherosclerosis.2024.117462_bib57","unstructured":"FANTOM5 CAGE profiles of human and mouse samples | Scientific Data\u2019. Accessed: Oct. 21, 2023. [Online]. Available: https:\/\/www.nature.com\/articles\/sdata2017112."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117462_bib58","article-title":"The gene ontology knowledgebase in 2023","volume":"224","author":"Aleksander","year":"2023","journal-title":"Genetics"},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2024.117462_bib59","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"Jassal","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2024.117462_bib60","doi-asserted-by":"crossref","first-page":"D648","DOI":"10.1093\/nar\/gkab1006","article-title":"The IntAct database: efficient access to fine-grained molecular interaction data","volume":"50","author":"del Toro","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117462_bib68","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet. Epidemiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117462_bib61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta\u2010analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117462_bib62","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117462_bib63","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117462_bib64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117462_bib65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.livres.2018.02.002","article-title":"The role of adipose tissue in fatty liver diseases","volume":"2","author":"Parker","year":"2018","journal-title":"Liver Research"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117462_bib66","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117462_bib67","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12967-023-04367-1","article-title":"Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy","volume":"21","author":"Zheng","year":"2023","journal-title":"J. Transl. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:45:33Z","timestamp":1770050733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024000224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":68,"alternative-id":["S0021915024000224"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117462","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prioritising genetic findings for drug target identification and validation","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117462"}}